Table of Contents
Cough, Cold and Allergy (hay Fever) Remedies in Hungary
Euromonitor
International
May 2009
List of Contents and Tables
Executive
Summary
Trend Towards Self-medication Drives Modest Market Development in
2008
Chemists/pharmacies Continue To Dominate OTC Healthcare
Distribution
Competitive Landscape in Analgesics Shifts Following 2007
Switches
Deregulation Leads To More Intense Competition in
Chemists/pharmacies
Self-medication Trend Will Continue To Benefit OTC
Healthcare Over 2008-2013
Key Trends and Developments
Economic and
Political Problems Inhibit OTC Healthcare Performance
OTC Healthcare
Distribution Outside Chemists/pharmacies Is Slow To Take Off
Algoflex
Attempts To Fill the Space Vacated by Algopyrin in Analgesics
Pharmacy
Deregulation Improves OTC Healthcare Distribution
Hungarians Continue To
Live Unhealthy Lifestyles
Market Indicators
Table 1 Consumer
Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life
Expectancy at Birth 2003-2008
Market Data
Table 3 Sales of OTC
Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by
Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by
Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Penetration of Private Label by Sector 2003-2008
Table 8 Sales of
OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 9 Sales
of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table
10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 11
Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
Appendix
OTC Registration and Classification
Advertising
Packaging
Labelling
Distribution
Vitamins & Dietary Supplements
Registration and Classification
EU Legislation
Self-medication and
Preventative Medicine
Generics
Switches
Summary 1 OTC Healthcare
Switches: 2005-2007 (note: re-switch: the status of drugs was changed formerly
from Rx to OTC, and current re-switch changed
Definitions
Summary 2
Research Sources
Egis Rt
Strategic Direction
Key Facts
Summary
3 Egis Rt: Key Facts
Summary 4 Egis Rt : Operational Indicators
2005-2007
Company Background
Production
Competitive
Positioning
Summary 5 Egis Rt: Competitive Position 2008
Extractum-pharma Rt
Strategic Direction
Key Facts
Summary 6
Extractum-Pharma Rt: Key Facts
Summary 7 Extractum-Pharma Rt: Operational
Indicators 2005-2007
Company Background
Production
Competitive
Positioning
Summary 8 Extractum-Pharma Rt: Competitive Position 2008
Pannonpharma Kft
Strategic Direction
Key Facts
Summary 9
PannonPharma Kft: Key Facts
Summary 10 PannonPharma Kft: Operational
Indicators 2005-2007
Company Background
Production
Competitive
Positioning
Summary 11 PannonPharma Kft: Competitive Position 2008
Richter Gedeon Rt
Strategic Direction
Key Facts
Summary 12 Richter
Gedeon Rt: Key Facts
Summary 13 Richter Gedeon Rt: Operational Indicators
2005-2007
Company Background
Production
Competitive
Positioning
Summary 14 Richter Gedeon Rt: Competitive Position 2008
Teva Magyarország Rt
Strategic Direction
Key Facts
Summary 15
Teva Magyarország Rt: Key Facts
Summary 16 Teva Magyarország Rt:
Operational Indicators 2005-2007
Company Background
Production
Competitive Positioning
Summary 17 Teva Magyarország Rt: Competitive
Position 2008
Headlines
Trends
Switches
Competitive
Landscape
Prospects
Sector Data
Table 12 Sales of Cough, Cold and
Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
Table 13 Sales
of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth
2003-2008
Table 14 Sales of Decongestants by Type: Value 2003-2008
Table 15 Sales of Decongestants by Type: % Value Growth 2003-2008
Table 16
Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type:
Value 2003-2008
Table 17 Sales of Child-specific Cough, Cold and Allergy
(Hay Fever) Remedies by Type: % Value Growth 2003-2008
Table 18 Herbal vs
Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
Table 19
Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value
2004-2008
Table 20 Cough, Cold and Allergy (Hay Fever) Remedies Brand
Shares by Value 2005-2008
Table 21 Forecast Sales of Cough, Cold and
Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
Table 22
Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: %
Value Growth 2008-2013
| 
View Cart
